Explore
Validate
Learn
Western blot
ImmunocytochemistryAntibody data
- Antibody Data
- Antigen structure
- References [10]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN145970 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Cyclin-Dependent Kinase 4 (CDK4) antibody
- Antibody type
- Monoclonal
- Antigen
- Recombinant full length protein (Human).
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Vial size
- 0.1 ml
- Storage
- Store at 4 C. Aliquot and store at -20 C long-term. Repeated freezing and thawing is not recommended. Storage in frost-free freezers is not recommended.
Submitted references Cell cycle checkpoints: preventing an identity crisis.
Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 control.
Aberrations of p16Ink4 and retinoblastoma tumour-suppressor genes occur in distinct sub-sets of human cancer cell lines.
Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16.
Cyclins and oncogenesis.
Mammalian G1 cyclins.
Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation.
Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins.
Human cyclins A and B1 are differentially located in the cell and undergo cell cycle-dependent nuclear transport.
Protein kinases and protooncogenes: biochemical regulators of the eukaryotic cell cycle.
Elledge SJ
Science (New York, N.Y.) 1996 Dec 6;274(5293):1664-72
Science (New York, N.Y.) 1996 Dec 6;274(5293):1664-72
Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 control.
Lukas J, Aagaard L, Strauss M, Bartek J
Cancer research 1995 Nov 1;55(21):4818-23
Cancer research 1995 Nov 1;55(21):4818-23
Aberrations of p16Ink4 and retinoblastoma tumour-suppressor genes occur in distinct sub-sets of human cancer cell lines.
Aagaard L, Lukas J, Bartkova J, Kjerulff AA, Strauss M, Bartek J
International journal of cancer. Journal international du cancer 1995 Mar 29;61(1):115-20
International journal of cancer. Journal international du cancer 1995 Mar 29;61(1):115-20
Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16.
Lukas J, Parry D, Aagaard L, Mann DJ, Bartkova J, Strauss M, Peters G, Bartek J
Nature 1995 Jun 8;375(6531):503-6
Nature 1995 Jun 8;375(6531):503-6
Cyclins and oncogenesis.
Motokura T, Arnold A
Biochimica et biophysica acta 1993 May 25;1155(1):63-78
Biochimica et biophysica acta 1993 May 25;1155(1):63-78
Mammalian G1 cyclins.
Sherr CJ
Cell 1993 Jun 18;73(6):1059-65
Cell 1993 Jun 18;73(6):1059-65
Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation.
Xiong Y, Zhang H, Beach D
Genes & development 1993 Aug;7(8):1572-83
Genes & development 1993 Aug;7(8):1572-83
Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins.
Matsushime H, Ewen ME, Strom DK, Kato JY, Hanks SK, Roussel MF, Sherr CJ
Cell 1992 Oct 16;71(2):323-34
Cell 1992 Oct 16;71(2):323-34
Human cyclins A and B1 are differentially located in the cell and undergo cell cycle-dependent nuclear transport.
Pines J, Hunter T
The Journal of cell biology 1991 Oct;115(1):1-17
The Journal of cell biology 1991 Oct;115(1):1-17
Protein kinases and protooncogenes: biochemical regulators of the eukaryotic cell cycle.
Freeman RS, Donoghue DJ
Biochemistry 1991 Mar 5;30(9):2293-302
Biochemistry 1991 Mar 5;30(9):2293-302
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- Image(s): Western Blotting
